Talphera (TLPH) Shares Outstanding (2010 - 2026)

Talphera's (TLPH) quarterly Shares Outstanding (Entity) came in at $34.5 million in Q2 2025, up 31.79% year-on-year from $26.2 million in Q2 2024, and up 31.45% quarter-over-quarter from $26.3 million in Q1 2025.

Talphera (TLPH) Shares Outstanding (2010 - 2026) Analysis & Trends

Talphera's Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $34.5 million for Q2 2025.

  • On a quarterly basis, Shares Outstanding (Entity) rose 31.79% year-over-year to $34.5 million in Q2 2025; TTM through Jun 2025 was $34.5 million, a 31.79% increase from a year earlier, with the FY2024 full-year figure at $25.8 million, up 52.46% from the prior year.
  • Shares Outstanding (Entity) climbed to $34.5 million in Q2 2025 per TLPH's latest filing, from $26.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $34.5 million in Q2 2025 and bottomed at $6.0 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Entity) is $11.0 million (2023), against an average of $15.3 million.
  • Across the five-year window, Shares Outstanding (Entity) jumped 138.32% in 2024 and grew 6.25% in 2025, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $6.8 million in 2021, then grew by 20.5% to $8.2 million in 2022, then soared by 105.64% to $17.0 million in 2023, then soared by 52.46% to $25.8 million in 2024, then surged by 33.6% to $34.5 million in 2025.
  • Per Business Quant, the three latest TLPH Shares Outstanding (Entity) figures stand at $34.5 million (Q2 2025), $26.3 million (Q1 2025), and $25.8 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Talphera 47.31 Mn 9.48 Mn - 69.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 69.82 Mn
Dec 31, 2025 42.41 Mn
Sep 30, 2025 41.45 Mn
Jun 30, 2025 34.53 Mn
Mar 31, 2025 26.27 Mn
Dec 31, 2024 25.85 Mn
Sep 30, 2024 26.21 Mn
Jun 30, 2024 26.20 Mn
Mar 31, 2024 24.72 Mn
Dec 31, 2023 14.26 Mn
Sep 30, 2023 16.76 Mn
Jun 30, 2023 10.92 Mn
Mar 31, 2023 10.89 Mn
Dec 31, 2022 7.39 Mn
Sep 30, 2022 7.38 Mn
Jun 30, 2022 7.36 Mn
Mar 31, 2022 7.28 Mn
Dec 31, 2021 5.99 Mn
Sep 30, 2021 5.96 Mn
Jun 30, 2021 5.96 Mn